Diligent Pharma
PrivateLast Round
Series A
May 15, 2023
Total Funding Raised
$8.27M
Company Overview
Diligent Pharma operates in Healthcare & Life Sciences and is based in Princeton, New Jersey. Its latest recorded funding round was a Series A round in May 2023.
Diligent Pharma is a pharmaceuticals and biotechnology company that provides a cloud-based research platform designed to streamline the selection and qualification of clinical trial service providers.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Compliance & Risk, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diligent Pharma Comparables
Compare Diligent Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strategikon Pharma | 76% | |
| ClinAI | 74% | |
| Veeva Systems | 72% |
For institutional investors. Book with your work email.
Diligent Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Diligent Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Series A |
| PJC | Series A |
| FCA Venture Partners | Series A |
Diligent Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Diligent Pharma's valuation, stock price, and market status.
Is Diligent Pharma a public or private company?
Diligent Pharma is a private company.
What is the current stock price of Diligent Pharma?
Diligent Pharma is a private company, so its shares have no public market price. Caplight tracks Diligent Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Diligent Pharma worth (valuation)?
Valuation information for Diligent Pharma is not publicly available.
Can I buy Diligent Pharma stock?
Diligent Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Diligent Pharma's last funding round?
Diligent Pharma's most recent funding round was Series A on May 15, 2023.
Who are the main investors in Diligent Pharma?
Key investors in Diligent Pharma include FCA Venture Partners.
Will Diligent Pharma IPO soon?
No public IPO plans have been announced for Diligent Pharma.
How can I track Diligent Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Diligent Pharma's shares on secondary markets.